TNFRSF13B and coronary artery disorder: Recently, in a cross-sectional study in patients with suspected CAD, TNFRSF13B/TACI (transmembrane activator and CAML interactor) was identified as predictive for the presence of high-risk atherosclerotic plaques on coronary computed tomographic angiography (10).